NKE
NIKE, Inc.
NKE has the edge over RGS overall, supported by lower modeled downside and stronger valuation.
RGS
Regis Corporation
RGS trails on the overall score without a compensating advantage in the available component scores.
NKE Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Strong |
NKE's profitability and balance sheet are currently healthy, and its revenue and cash flow are stable.
RGS Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Stable | |
| Stable | |
| Under pressure |
RGS's profitability and cash flow are currently stable, but its revenue and balance sheet are under pressure.
NKE PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $37.76 | — |
| Cheap | 23x | $47.70 | +26% |
| Forward | 30x | $37.76 | — |
| Fair | 33x | $68.16 | +80% |
| Expensive | 47x | $97.86 | +159% |
Historical ranges are pointers, not guarantees.
NKE has the edge over RGS in the historical PE scenario, which offers more potential upside but is not a forecast.
RGS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 0.5x | $1.05 | -96% |
| Fair | 0.6x | $1.27 | -95% |
| Expensive | 0.7x | $1.39 | -94% |
| Current | 11x | $23.55 | — |
Historical ranges are pointers, not guarantees.
RGS's PE is in its expensive range at 11x.
NKE Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Stable | |
| Decline | |
| Improving | |
| Moderate | |
| Low |
Analysts expect NKE's profitability to improve, but its revenue to decline. However, they disagree widely on these estimates.
RGS Forward outlook
There aren't enough analyst estimates for RGS to show an outlook.
NKE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.27 | -39% |
| Q3 2026 | $2.09 | +7.2% |
| Q2 2026 | $2.10 | -2.8% |
| Q1 2026 | $1.51 | -50% |
| Q4 2025 | $1.70 | -48% |
| Q3 2025 | $1.95 | -44% |
| Q2 2025 | $2.16 | -42% |
| Q1 2025 | $3.01 | -11% |
| Q4 2024 | $3.24 | -5.3% |
NKE's earnings per share have fallen from their peak: $2.09 over the past year, against $3.82 in late 2021.
RGS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $2.10 | -96% |
| Q2 2026 | $2.41 | -95% |
| Q1 2026 | $44.58 | +9.4% |
| Q4 2025 | $44.40 | +12% |
| Q3 2025 | $46.95 | +26% |
| Q2 2025 | $46.10 | +20% |
| Q1 2025 | $40.74 | +$42.71 |
| Q4 2024 | $39.66 | +$41.43 |
RGS has the edge over NKE on earnings, with more consistent year-over-year improvement.
NKE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $11.2B | -4.3% |
| Q2 2026 | $11B | -1.1% |
| Q1 2026 | $11.3B | +0.1% |
| Q4 2025 | $12.4B | +0.6% |
| Q3 2025 | $11.7B | +1.1% |
| Q2 2025 | $11.1B | -12% |
| Q1 2025 | $11.3B | -9.3% |
| Q4 2024 | $12.4B | -7.7% |
NKE's revenue fell from its 2023 peak and has held roughly level since: $11.2B last quarter, down 4.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8.2% | +0.3 points |
| Q2 2026 | 12% | +9.2 points |
| Q1 2026 | 5.8% | -1.7 points |
| Q4 2025 | 8% | -3.4 points |
| Q3 2025 | 7.9% | -3.4 points |
| Q2 2025 | 2.9% | -11 points |
| Q1 2025 | 7.5% | -3.8 points |
| Q4 2024 | 11% | -2.9 points |
NKE's operating margin was 8.2% last quarter, about level with the same quarter a year ago.
RGS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $54.3M | -7.8% |
| Q2 2026 | $56M | -7.3% |
| Q1 2026 | $52.4M | -8% |
| Q4 2025 | $57.1M | +22% |
| Q3 2025 | $59M | +28% |
| Q2 2025 | $60.4M | +22% |
| Q1 2025 | $57M | +16% |
| Q4 2024 | $46.7M | -8.5% |
RGS has the edge over NKE on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 9.8% | -0.3 points |
| Q2 2026 | 12% | -0.3 points |
| Q1 2026 | 11% | +2.1 points |
| Q4 2025 | 11% | -0.9 points |
| Q3 2025 | 10% | +5.4 points |
| Q2 2025 | 12% | +2.8 points |
| Q1 2025 | 8.8% | +0.5 points |
| Q4 2024 | 12% | +2.4 points |
RGS has the edge over NKE on profitability, with a higher operating margin.
NKE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$64M | -527% |
| Q2 2026 | $1.5B | +313% |
| Q1 2026 | $284M | -83% |
| Q4 2025 | $386M | -58% |
| Q3 2025 | $15M | -95% |
| Q2 2025 | $363M | -85% |
| Q1 2025 | $1.7B | -11% |
| Q4 2024 | $920M | -65% |
NKE usually generates cash, though not every quarter: the latest was −$64M, but it generated $2.1B over the past year.
RGS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $2.1M | +11% |
| Q2 2026 | $3.6M | -42% |
| Q1 2026 | $4.8M | -19% |
| Q4 2025 | $891K | -48% |
| Q3 2025 | $1.9M | +$3.2M |
| Q2 2025 | $6.2M | +23% |
| Q1 2025 | $5.9M | +$6.2M |
| Q4 2024 | $1.7M | +$5.9M |
RGS has the edge over NKE on cash flow, with more consistent year-over-year improvement.
NKE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +3.2M shares |
| 1 year | +0.4% | +5.2M shares |
| 3 years | -3.8% | -59.1M shares |
| 5 years | -8.4% | -135M shares |
| Available history | -6.9% | -110M shares |
NKE has the edge over RGS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | $20M |
| Q3 2025 | $126M |
| Q2 2025 | $199M |
| Q1 2025 | $506M |
| Q4 2024 | $1.1B |
NKE has spent almost nothing on buybacks in the past year.
RGS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.5% | +44K shares |
| 1 year | +5.1% | +142K shares |
| 3 years | +24% | +561K shares |
| 5 years | +59% | +1.1M shares |
| Available history | +63% | +1.1M shares |
RGS has 3M diluted shares, up 5.1% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2021 | — |
| Q1 2021 | — |
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
| Q4 2019 | $1,000 |
NKE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.2x | Very low |
| Q2 2026 | 0.1x | Very low |
| Q1 2025 | 0.1x | Very low |
| Q4 2024 | 0.2x | Very low |
| Q3 2024 | 0.1x | Very low |
| Q2 2024 | -0.1x | Net Cash |
| Q1 2024 | -0.0x | Very low |
| Q4 2023 | 0.1x | Very low |
NKE has the edge over RGS on leverage, with a lower net debt burden relative to earnings.
RGS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.2x | Elevated |
| Q2 2026 | 3.2x | Elevated |
| Q1 2026 | 3.2x | Elevated |
| Q4 2025 | 3.4x | Elevated |
| Q3 2025 | 3.5x | Elevated |
| Q2 2025 | 4.1x | High |
| Q1 2025 | 4.8x | High |
| Q4 2024 | 5.2x | High |
RGS's net debt is about 3.2 years of its operating earnings (EBITDA), down from 3.5 years a year ago.
NKE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.0 | Neutral |
| Stochastic | 57.5 | Neutral |
NKE's weekly RSI is 40 (neutral) and its Stochastic is 58 (neutral).
RGS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.3 | Neutral |
| Stochastic | 35.1 | Neutral |
RGS's weekly RSI is 36 (neutral) and its Stochastic is 35 (neutral).
NKE PE vs Consumer Cyclical Sector
| Metric | NKE | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 18x | 0.3% above |
| PE % | 2 | 47 | 45 pts below |
NKE is trading at 18x earnings, in line with the Consumer Cyclical sector's median of 18x.
RGS PE vs Consumer Cyclical Sector
| Metric | RGS | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 18x | 38% below |
| PE % | 92 | 47 | 45 pts above |
RGS has the edge over NKE on valuation relative to its sector.
NKE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $36.7 | 2.8% above |
| 20 week MA | $39.2 | 3.6% below |
| 50 week MA | $48.0 | 21% below |
| 100 week MA | $58.4 | 35% below |
| 200 week MA | $79.2 | 52% below |
NKE has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 52% below its 200-week average.
RGS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.8 | 15% below |
| 20 week MA | $27.7 | 15% below |
| 50 week MA | $26.5 | 11% below |
| 100 week MA | $24.8 | 5% below |
| 200 week MA | $21.2 | 11% above |
RGS has fallen below most of its moving averages, though it's still 11% above its 200-week average.
NKE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $101.6 | $141.6 | +39% |
| 2021 | $141.6 | $165.7 | +17% |
| 2022 | $165.7 | $116.3 | -30% |
| 2023 | $116.3 | $108.6 | -6.6% |
| 2024 | $108.6 | $76.4 | -30% |
| 2025 | $76.4 | $60.9 | -20% |
| 2026 YTD | $60.9 | $37.8 | -38% |
NKE has finished four years in a row lower, and it's down 38% so far in 2026.
RGS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $359.0 | $189.6 | -47% |
| 2021 | $189.6 | $33.8 | -82% |
| 2022 | $33.8 | $24.2 | -28% |
| 2023 | $24.2 | $9.45 | -61% |
| 2024 | $9.45 | $25.5 | +170% |
| 2025 | $25.5 | $27.4 | +7.4% |
| 2026 YTD | $27.4 | $23.6 | -14% |
RGS has the edge over NKE on returns for 2026, with the stronger performance.